Lv1
30 积分 2024-05-11 加入
Deciphering the shared genetic architecture between bipolar disorder and body mass index
4小时前
已完结
Why does GLP‐1 agonist combined with GIP and/or GCG agonist have greater weight loss effect than GLP‐1 agonist alone in obese adults without type 2 diabetes?
6小时前
已完结
Unravelling the GIPR agonist versus antagonist paradox
1天前
已完结
Association of Hepatitis C Virus With Alcohol Use Among U.S. Adults: NHANES 2003–2010
6天前
已完结
Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease
4个月前
已完结
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
4个月前
已完结
Nature's randomised trials
5个月前
已完结
Investigating the shared genetic architecture of post-traumatic stress disorder and gastrointestinal tract disorders: a genome-wide cross-trait analysis
5个月前
已完结
Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions?
5个月前
已完结
Glucagon-like peptide 1 agonists, weight and blood pressure change after smoking cessation
5个月前
已关闭
皖公网安备34019202002308
